While more research is needed in this area, a study looking at GLP1 receptor agonist use and opioid overdose risk in patients with type 2 diabetes and opioid use disorder (OUD) found that semaglutide was associated with reduced opioid overdose risk in patients with comorbid T2D and OUD
GLP-1 receptor agonists are a class of prescription medications originally developed for the management of type 2 diabetes and subsequently studied for use in weight management in eligible adults
Lets explore more about its effects in this article
Tilg, H., Ianiro, G., Gasbarrini, A
That said, here is how we think about it in practice
Animal milk composition, drug metabolism, and dosage can all be very different from what happens in people